| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT06176352 A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal… |
Trial completed |
| 2026-05-27 | NCT06847542 A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD |
date change Primary completion pushed: 2028-09-12 -> 2028-11-15 |
| 2026-05-27 | NCT06847542 A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD |
date change Completion pushed: 2028-10-12 -> 2028-11-15 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04853251 | A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related… | Neovascular Age-related Macular Degeneration | Recruiting |
| Phase 3 | |||
| NCT07515079 | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema | Diabetic Macular Edema (DME) | Recruiting |
| NCT06847542 | A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT05562947 | A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System… | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT04657289 | A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the… | Neovascular Age-related Macular Degeneration (nAMD) | Active, Not Recruiting |
| NCT04444492 | Combination of Ranibizumab and Targeted Laser Photocoagulation | Central Retinal Vein Occlusion With Macular Edema | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT06957080 | A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME | Diabetic Macular Edema (DME) | Active, Not Recruiting |
| NCT04704921 | Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via… | AMD | Active, Not Recruiting |
| Phase 2 | |||
| NCT04514653 | RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With… | Neovascular Age-Related Macular Degeneration (nAMD) | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04567303 | Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration | Macular Degeneration | Active, Not Recruiting |